ArticleBMC public health2014
Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints.
Article in BMC public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Epidemiology and Economic Burden of Obesity and Related Cardiometabolic Disorders in the United Arab Emirates: A Systematic Review and Qualitative Synthesis.Journal of obesity · 2018Pooled it
- Towards a burden of disease research agenda.Population health metrics · 2026Article
- Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual framework.International journal for equity in health · 2025Review
- Article
- Article
- Local approach to attributable disease burden: a case study on air pollution and mortality in Belgium.BMC public health · 2025Article
- Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Standardised reporting of burden of disease studies: the STROBOD statement.Population health metrics · 2024Article
- Article
- Article
- Measuring the Burden of Disease in Korea Using Disability-Adjusted Life Years (2008-2020).Journal of Korean medical science · 2024Article
- Knowledge management tools and mechanisms for evidence-informed decision-making in the WHO European Region: a scoping review.Health research policy and systems · 2023Article
- Clinical Cancer Research in South America and Potential Health Economic Impacts.Healthcare (Basel, Switzerland) · 2023Article
- Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020.PloS one · 2023Article
- Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.Dermatology and therapy · 2022Review
- The state of health in Belgium, 1990-2019: a benchmarking analysis based on the Global Burden of Disease 2019 study.Archives of public health = Archives belges de sante publique · 2022Article
- Belgian population norms for the EQ-5D-5L, 2018.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022Article
- Recommendations to plan a national burden of disease study.Archives of public health = Archives belges de sante publique · 2021Article
- The Burden of Obesity in Egypt.Frontiers in public health · 2021Article
- Reflections on key methodological decisions in national burden of disease assessments.Archives of public health = Archives belges de sante publique · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundTo support public health policy, information on the burden of disease is essential. In recent years, the Disability-Adjusted Life Year (DALY) has emerged as the most important summary measure of public health. DALYs quantify the number of healthy life years lost due to morbidity and mortality, and thereby facilitate the comparison of the relative impact of diseases and risk factors and the monitoring of public health over time. DISCUSSION: Evidence on the disease burden in Belgium, expressed as DALYs, is available from international and national efforts. Non-communicable diseases and injuries dominate the overall disease burden, while dietary risks, tobacco smoking, and high body-mass index are the major risk factors for ill health. Notwithstanding these efforts, if DALYs were to be used for guiding health policy, a more systematic approach is required. By integrating DALYs in the current data generating systems, comparable estimates, rooted in recent local data, can be produced. This might however be hampered by several restrictions, such as limited harmonization, timeliness, inclusiveness and accessibility of current databases. SUMMARY: Routine quantification of disease burden in terms of DALYs would provide a significant added value to evidence-based public health policy in Belgium, although some hurdles need to be cleared.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.